High-performance liquid chromatographic determination of spironolactone and its metabolites in human biological fluids after solid-phase extraction.
A simple and sensitive high-performance liquid chromatographic procedure to determine spironolactone and its three major metabolites in biological specimens is described. The assay involves sequential extraction on C18 and CN solid phases, and subsequent separation on a reversed-phase column. In plasma samples, spironolactone and its metabolites were completely separated within 8 min using an isocratic mobile phase, while in urine samples a methanol gradient was necessary to achieve a good separation within 14 min. Recoveries for all analytes were greater than 80% in plasma and 72% in urine. Linear responses were observed for all compounds in the range 6.25-400 ng/ml for plasma and 31.25-2000 ng/ml for urine. The plasma and urine methods were precise (coefficient of variation from 0.8 to 12.5%) and accurate (-12.1% to 7.4% of the nominal values) for all compounds. The assay proved to be suitable for the pharmacokinetic study of spironolactone in healthy human subjects.
Varin
F
F
Faculté de Pharmacie, Université de Montréal, Canada.
The Minh
T u
Tu
Benoît
F
F
Villeneuve
J P
JP
Théorêt
Y
Y
D002851:Chromatography, High Pressure Liquid; D006801:Humans; D013056:Spectrophotometry, Ultraviolet; D013148:Spironolactone / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine
D013148:Spironolactone